Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 45Uterine Cervical Neoplasms 10Melanoma 10Endometrial Neoplasms 9Mouth Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Intraductal, Noninfiltrating 4Vulvar Neoplasms 3Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Uterine Neoplasms 2Ovarian Neoplasms 2Neoplasm Micrometastasis 2Neoplasm Metastasis 2Lymphatic Metastasis 2Leukemia, Lymphocytic, Chronic, B-Cell 2Head and Neck Neoplasms 2Eccrine Porocarcinoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms, Male 2Breast Carcinoma In Situ 2Anus Neoplasms 2Waldenstrom Macroglobulinemia 1Sentinel Lymph Node Biopsy (SLNB) 1Sentinel Lymph Node 1Sarcoidosis, Pulmonary 1Sarcoidosis 1Rhabdomyosarcoma 1Recurrence 1

Interventions

Hysterectomy 2ipatasertib 1entinostat 1Telemedicine 1Specimen Handling 1Sentinel Lymph Node Biopsy 1Ovariectomy 1Megestrol Acetate 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Health Promotion 1Exercise Test 1Educational Status 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma × Sentinel Lymph Node Biopsy × Clear all
NCT04604613 2026-03-09

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

M.D. Anderson Cancer Center

Active not recruiting
518 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡